Enwei Pharmaceutical's unsatisfactory performance in terms o...

Enwei Pharmaceutical's unsatisfactory performance in terms of earnings growth, poor ROE, and high payout ratio raise concerns about its future prospects. The company's decision to pay dividends over earnings growth could be risky in the long term.